TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward

TR Guilarte - Pharmacology & therapeutics, 2019 - Elsevier
Abstract The use of Translocator Protein 18 kDa (TSPO) as a clinical neuroimaging
biomarker of brain injury and neuroinflammation has increased exponentially in the last …
被引用次数：150 相关文章

[引用][C] TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward

TR Guilarte - Pharmacology & Therapeutics, 2019 - cir.nii.ac.jp
TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[HTML] nih.gov

[HTML][HTML] TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward

TR Guilarte - Pharmacology & therapeutics, 2019 - ncbi.nlm.nih.gov
Abstract The use of Translocator Protein 18 kDa (TSPO) as a clinical neuroimaging
biomarker of brain injury and neuroinflammation has increased exponentially in the last …

TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward.

TR Guilarte - Pharmacology & Therapeutics, 2018 - europepmc.org
Abstract The use of Translocator Protein 18 kDa (TSPO) as a clinical neuroimaging
biomarker of brain injury and neuroinflammation has increased exponentially in the last …

TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward

TR Guilarte - Pharmacology & therapeutics, 2019 - pubmed.ncbi.nlm.nih.gov
The use of Translocator Protein 18 kDa (TSPO) as a clinical neuroimaging biomarker of
brain injury and neuroinflammation has increased exponentially in the last decade. There …

TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward.

TR Guilarte - Pharmacology & Therapeutics, 2018 - europepmc.org
Abstract The use of Translocator Protein 18 kDa (TSPO) as a clinical neuroimaging
biomarker of brain injury and neuroinflammation has increased exponentially in the last …